Form 4 for BIOA BioAge Labs, Inc.
Accepted 2024-09-27 00:00:00 ET · period of report 2024-09-25 · accession 0001415889-24-024046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-09-27 | 2024-09-27 | BIOA | ENRIGHT PATRICK G | Dir | C - Cnv Deriv | — | +1.31M | 1.31M | New | — |
| DI | 2024-09-27 | 2024-09-27 | BIOA | ENRIGHT PATRICK G | Dir | P - Purchase | $18.00 | +400.0K | 1.71M | +31% | +$7.20M |
| DI | 2024-09-27 | 2024-09-27 | BIOA | ENRIGHT PATRICK G | Dir | C - Cnv Deriv | — | -5.85M | 0 | -100% | — |
| D | 2024-09-27 | 2024-09-25 | BIOA | ENRIGHT PATRICK G | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-27 | C | A | 1,310,589 | — | 1,310,589 | I Longitude Venture Partners IV, L.P. | — | — | (F1) Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614. The securities have no expiration date. (F2) These shares are directly held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to exercise voting and investment discretion with respect to securities held by LVP IV. The reporting person and Ms. Juliet Tammenoms Bakker serve as the managing members of LCP IV and may be deemed to share voting and investment discretion with respect to securities held directly by LVP IV. Each of LCP IV, Mr. Enright, and Ms. Tammenoms Bakker disclaims beneficial ownership of such securities and this report shall not be deemed an admission that any of them is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| 2 | Common | Common Stock | 2024-09-27 | P | A | 400,000 | $18.00 | 1,710,589 | I Longitude Venture Partners IV, L.P. | — | — | (F2) These shares are directly held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to exercise voting and investment discretion with respect to securities held by LVP IV. The reporting person and Ms. Juliet Tammenoms Bakker serve as the managing members of LCP IV and may be deemed to share voting and investment discretion with respect to securities held directly by LVP IV. Each of LCP IV, Mr. Enright, and Ms. Tammenoms Bakker disclaims beneficial ownership of such securities and this report shall not be deemed an admission that any of them is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| 3 | Derivative | Series D Preferred Stock | 2024-09-27 | C | D | 5,848,637 | — | 0 | I Longitude Venture Partners IV, L.P. | — · — to — | 1,310,589 Common Stock | (F1) Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614. The securities have no expiration date. (F2) These shares are directly held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to exercise voting and investment discretion with respect to securities held by LVP IV. The reporting person and Ms. Juliet Tammenoms Bakker serve as the managing members of LCP IV and may be deemed to share voting and investment discretion with respect to securities held directly by LVP IV. Each of LCP IV, Mr. Enright, and Ms. Tammenoms Bakker disclaims beneficial ownership of such securities and this report shall not be deemed an admission that any of them is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-09-25 | A | A | 15,000 | $0.00 | 15,000 | D | $18.00 · — to 2034-09-24 | 15,000 Common Stock | (F3) The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date. |